Revlimid and Cobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Revlimid (lenalidomide) and Cobalamin (vitamin b12). Common drug interactions include dysgeusia among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Revlimid and Cobalamin. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Cobalamin?

Cobalamin has active ingredients of vitamin b12. eHealthMe is studying from 3,429 Cobalamin users. Check the latest studies of Cobalamin.

On Jul, 20, 2026

32 people who take Revlimid and Cobalamin together, and have interactions are studied.

Revlimid and Cobalamin drug interactions.

What are the common drug interactions of Revlimid and Cobalamin, by gender? *:

female:

Dysgeusia (disorder of the sense of taste)
Productive cough
Inappropriate antidiuretic hormone secretion
Human chorionic gonadotropin increased
Osteonecrosis of jaw (death of bone of jaw)
Pregnancy test false positive
Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Swelling face
Anaemia (lack of blood)

male:

Platelet count decreased
White blood cell count decreased
Hyperkalaemia (damage to or disease of the kidney)
Constipation
Nausea (feeling of having an urge to vomit)
Administration site pain
Arthralgia (joint pain)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Axillary pain
Blood creatinine increased

What are the common drug interactions of Revlimid and Cobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Human chorionic gonadotropin increased
Pregnancy test false positive
Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
Herpes zoster
Natural killer cell count decreased (natural killer cell number reduced)

60+:

Platelet count decreased
White blood cell count decreased
Hyperkalaemia (damage to or disease of the kidney)
Drug eruption (adverse drug reaction of the skin)
Nausea (feeling of having an urge to vomit)
Thrombocytopenia (decrease of platelets in blood)
Administration site pain
Arthralgia (joint pain)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
Axillary pain

What are the existing conditions these people have? *

Pain: 5 people, 15.62%
Resorption Bone Increased: 4 people, 12.50%
Osteoporosis (bones weak and more likely to break): 4 people, 12.50%
Osteolysis (dissolution of bone): 4 people, 12.50%
Urinary Tract Infection: 3 people, 9.38%
Vitamin B12 Decreased: 2 people, 6.25%
Heart Rate Irregular: 2 people, 6.25%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.25%
Fever: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and Cobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously